MedPath

Internet-based guided self-help for social anxiety disorder administered through a mobile app

Completed
Conditions
Social anxiety disorder
Mental and Behavioural Disorders
Registration Number
ISRCTN10627379
Lead Sponsor
Swiss National Science Foundation
Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29781648

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. Male and female at least 18 years of age
2. Provided written consent
3. Sufficient German language skills
4. Access to computer with internet connection
5. Exceeding pre-defined cut-off scores in one of the social anxiety measures
6. Meeting the diagnostic criteria for SAD according to the diagnostic telephone interview
7. Agreeing to undergo no other psychological treatment for the duration of the study

Exclusion Criteria

1. Active suicidal plans (according to the suicide item of the Beck Depression Inventory (BDI) or the diagnostic telephone interview)
2. History of psychotic or bipolar disorders
3. Prescribed medication for anxiety or depression only if the dosage has been changed during the last month prior to the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Symptoms of SAD (Social Phobia Scale [SPS], assessed using Social Interaction Anxiety Scale [SIAS], and Liebowitz Social Anxiety Scale-Self-Report [LSAS-SR]), pre, post (12 weeks), follow-up (6 months)<br>2. Diagnostic status (Structured Clinical Interview for DSM-IV Axis I Disorders [SCID-I]): pre, post (12 weeks), follow-up (6 months)
Secondary Outcome Measures
NameTimeMethod
1. Depression, assessed using the Beck Depression Inventory [BDI-II]: pre, post (12 weeks), follow-up (6 months)<br>2. General symptomatology, assessed using the Brief Symptom Inventory [BSI]: pre, post (12 weeks), follow-up (6 months)<br>3. Interpersonal problems, assessed using the Inventory of Interpersonal Problems (IIP-64): pre, post (12 weeks), follow-up (6 months)<br>4. Quality of life, assessed using the SF-12 Health Survey: pre, post (12 weeks), follow-up (6 months)<br>5. Client Satisfaction, assessed using the ZUF-8 general satisfaction questionnaire: post (12 weeks)<br>6. Several process measures:<br>6.1. Change in SAD symptoms: week 2, 4, 6, 8, 10<br>6.2. Individual condition, assessed using the Working Alliance Inventory-Short Revised (WAI-SR): week 2, 4, 6, 8, 10<br>6.3. Treatment expectancy, assessed using the Credibility/Expectancy Questionnaire (CEQ): week 2
© Copyright 2025. All Rights Reserved by MedPath